Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIMV
1901
DELISTED
ZimVie
ZIMV
| $12.1M | ﹤0.01% |
732,862
-28,423
| -4% | -$506K |
|
1902
NETGEAR
NTGR
$648M
| $12.1M | ﹤0.01% |
765,732
+42,486
| +6% | +$619K |
|
|
RWT
1903
Redwood Trust
RWT
$580M
| $12M | ﹤0.01% |
1,889,886
+91,626
| +5% | +$598K |
|
1904
Sea Limited
SE
$68.1B
| $11.9M | ﹤0.01% |
222,344
+13,862
| +7% | +$638K |
|
1905
Credicorp
BAP
$31.4B
| $11.9M | ﹤0.01% |
70,388
+176
| +0.3% | +$28.3K |
|
1906
iShares Russell 1000 Value ETF
IWD
$82.6B
| $11.8M | ﹤0.01% |
66,090
-4,449
| -6% | -$753K |
|
1907
Asana
ASAN
$1.97B
| $11.7M | ﹤0.01% |
758,239
+61,962
| +9% | +$1.11M |
|
1908
ADMA Biologics
ADMA
$2.03B
| $11.7M | ﹤0.01% |
1,775,120
+138,417
| +8% | +$757K |
|
1909
Levi Strauss
LEVI
$9.48B
| $11.7M | ﹤0.01% |
585,591
+37,408
| +7% | +$650K |
|
1910
Sprinklr
CXM
$1.53B
| $11.7M | ﹤0.01% |
953,633
+47,877
| +5% | +$610K |
|
1911
Unitil
UTL
$963M
| $11.7M | ﹤0.01% |
223,417
+10,355
| +5% | +$521K |
|
1912
Bumble
BMBL
$403M
| $11.6M | ﹤0.01% |
1,025,881
+41,826
| +4% | +$533K |
|
|
ADAM
1913
Adamas Trust
ADAM
$848M
| $11.6M | ﹤0.01% |
1,615,887
+88,111
| +6% | +$672K |
|
1914
Novartis
NVS
$292B
| $11.6M | ﹤0.01% |
120,604
-25,805
| -18% | -$2.65M |
|
1915
Select Water Solutions
WTTR
$2.29B
| $11.6M | ﹤0.01% |
1,255,481
+172,346
| +16% | +$1.39M |
|
|
PRA
1916
DELISTED
ProAssurance
PRA
| $11.6M | ﹤0.01% |
900,526
+7,662
| +0.9% | +$98.6K |
|
1917
Usana Health Sciences
USNA
$422M
| $11.6M | ﹤0.01% |
238,706
+16,283
| +7% | +$797K |
|
|
BRY
1918
DELISTED
Berry Corp
BRY
| $11.6M | ﹤0.01% |
1,435,342
+228,019
| +19% | +$1.59M |
|
|
BRKL
1919
DELISTED
Brookline Bancorp
BRKL
| $11.6M | ﹤0.01% |
1,160,079
+68,234
| +6% | +$690K |
|
|
MORF
1920
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $11.5M | ﹤0.01% |
326,697
+7,247
| +2% | +$243K |
|
|
EVBG
1921
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $11.4M | ﹤0.01% |
328,650
-42,628
| -11% | -$1.2M |
|
1922
AtriCure
ATRC
$1.97B
| $11.4M | ﹤0.01% |
375,841
+8,690
| +2% | +$291K |
|
1923
World Acceptance Corp
WRLD
$877M
| $11.4M | ﹤0.01% |
78,859
-254
| -0.3% | -$33.3K |
|
1924
Manitowoc
MTW
$514M
| $11.4M | ﹤0.01% |
808,023
+34,458
| +4% | +$511K |
|
1925
Teekay Tankers
TNK
$2.79B
| $11.4M | ﹤0.01% |
195,139
+14,406
| +8% | +$814K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.